CA
FOLD

Corrado Advisors’s Amicus Therapeutics FOLD Stock Holding History

Corrado Advisors’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-37,325
Closed -$451K – 92
2018
Q3 		$451K Buy
37,325
+455
+1% +$6.36K 0.29% 56
2018
Q2 		$575K Buy
36,870
+4,514
+14% +$68.2K 0.35% 56
2018
Q1 		$487K Sell
32,356
-2,050
-6% -$31.2K 0.29% 58
2017
Q4 		$495K Hold
34,406
– – 0.29% 60
2017
Q3 		$519K Sell
34,406
-2,499
-7% -$33.1K 0.29% 63
2017
Q2 		$372K Sell
36,905
-10,620
-22% -$85.5K 0.2% 78
2017
Q1 		$339K Buy
47,525
+6,825
+17% +$43.2K 0.19% 79
2016
Q4 		$202K Sell
40,700
-2,295
-5% -$15.9K 0.13% 97
2016
Q3 		$318K Buy
42,995
+31,795
+284% +$215K 0.2% 77
2016
Q2 		$61K Buy
+11,200
New +$78.3K 0.04% 101

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Corrado Advisors's FOLD Position: Q4 2018 in Review

Corrado Advisors sold out of Amicus Therapeutics (FOLD) in Q4 2018, closing a stake of 37,325 shares — an estimated $451K sold.

Corrado Advisors first reported a position in FOLD in Q2 2016 and held it in 10 quarters. The position peaked at $575K in Q2 2018. 195 funds tracked by Wall St. Rank hold FOLD as of Q4 2018.

  • Corrado Advisors reported no remaining Amicus Therapeutics position as of Q4 2018 after selling out during the quarter.
  • Corrado Advisors sold 37,325 Amicus Therapeutics shares in Q4 2018, an estimated $451K.
  • Corrado Advisors first reported a position in Amicus Therapeutics in Q2 2016 and held it in 10 quarters.
  • Corrado Advisors's Amicus Therapeutics position peaked at $575K in Q2 2018.
  • 195 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2018.

Based on Corrado Advisors's 13F filing for Q4 2018, filed 9 Jan 2019.